1211 PDev QT
BioCentury & Getty Images

Product Development

Dec. 11 Quick Takes: AZ to run combo trial with Sputnik; plus Phase III hits for Lilly, AbbVie and TG, data from Immutep, NVS, Mycovia, Sarepta and Greenwich

Dec 12, 2020 | 2:26 AM GMT

Russian and AZ COVID vaccines in combo trial
AstraZeneca plc (LSE:AZN; NASDAQ:AZN) will begin by year-end a clinical trial of its AZD1222, developed with the University of Oxford, in combination with the adenovirus serotype 26 (Ad26) component of

Read the full 766 word article

How to gain access

Continue reading with a
two-week free trial.